Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Seagen Inc (NQ: SGEN )

212.15 -0.09 (-0.04%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Seagen Inc

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Week In Review: Livzon In-Licenses GERD Therapy In $127 Million Agreement
Livzon Pharmaceutical Group entered a $127.5 million agreement for China rights to a gastroesophageal reflux disease therapy from Onconic Therapeutics. Meanwhile, Gracell Biotech announced that it had... 
Via Talk Markets
Stock Market Diverges Amid Bank Woes, Growth Gains; First Republic, Credit Suisse, Meta In Focus: Weekly Review
A market rally is underway, but bank stocks kept tumbling. 
Via Investor's Business Daily
This Must-Buy Dividend Growth Stock Could Pay You for Life
It might not regularly beat the market, but it won't have any trouble padding your wallet. 
Via The Motley Fool
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time for another dive into the biggest pre-market stock movers as we go over all the latest news for Thursday morning! 
Via InvestorPlace
Here's How Much You Would Have Made Owning Seagen Stock In The Last 5 Years
Via Benzinga
A Bullish Sign Appears On Seagen's Chart
Via Benzinga
Why Seagen Stock Is Soaring Today
Investors are cheering Pfizer's planned acquisition of Seagen. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For March 15, 2023
Via Benzinga
Drug Companies Raising Prices Greater Than Inflation? US Government Mulling Imposing Fines
Under Joe Biden's signature Inflation Reduction Act, drugmakers for twenty-seven drugs will be penalized for charging prices that rise faster than inflation for people with disabilities or the elderly... 
Via Benzinga
Meta Platforms To Rally Over 36%? Here Are 10 Other Analyst Forecasts For Wednesday
Credit Suisse cut the price target for Zscaler, Inc. (NASDAQ: ZS) from $275 to $165. Credit Suisse analyst Sami Badri maintained an Outperform rating. Zscaler shares fell 1.9% to $105.95 in pre-market... 
Via Benzinga
Check Out What Whales Are Doing With SGEN
Via Benzinga
Seagen Unusual Options Activity For March 13
Via Benzinga
(SGEN) - Analyzing Seagen's Short Interest
Via Benzinga
Does This Billion-Dollar Deal Solve Pfizer's Biggest Problem?
Pfizer's planned acquisition of Seagen could be a very important move. 
Via The Motley Fool
Key Inflation Meter Doesn't Show New Signs for Concern and Stocks Begin Shaking Off Instability
(Tuesday Market Open) The first of this week’s three critical data releases, February’s Consumer Price Index (CPI), was pretty much in line with expectations Tuesday, perhaps easing some concerns about... 
Via Benzinga
Is Pfizer Stock a Screaming Buy After Its $43 Billion Seagen Acquisition?
Pfizer's $43 billion Seagen acquisition is a long-term value-creation strategy. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For March 14, 2023
Via Benzinga
These Analysts Boost Price Targets On Seagen Following Acquisition News
Pfizer Inc (NYSE: PFE) agreed to acquire Seagen Inc (NASDAQ: SGEN) for $229 in cash per Seagen share for a total enterprise value of $43 billion. Seagen shares jumped 14.5% to close at $197.65 on... 
Via Benzinga
Jabil To Rally Around 23%? Here Are 10 Other Analyst Forecasts For Tuesday
Raymond James raised the price target for Jabil Inc. (NYSE: JBL) from $84 to $100. Raymond James analyst Melissa Fairbanks maintained a Strong Buy rating. Jabil shares fell 0.7% to close at $81.35 on... 
Via Benzinga
Did Elon Musk Just Put His Skepticism Behind And Warm Up To mRNA Tech That Powers Most COVID-19 Vaccines?
Tesla CEO Elon Musk has been a skeptic of the COVID-19 vaccines and highly critical of Dr. 
Via Benzinga
Monday Merger Mania Just Made These 2 Biotech Stocks Big Winners
On a volatile market day, companies are still looking for smart combinations. 
Via The Motley Fool
Why Bank Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Provention Bio, Inc. (NASDAQ: PRVB) shares jumped 250.8% to $23.50 after Sanofi announced it will acquire the company for $25 per share in cash. 
Via Benzinga
SGEN Stock Alert: Pfizer Buys Seagen in GIANT $43 Billion Deal
Seagen (SGEN) stock is taking off on Monday as investors react to a $43 billion acquisition agreement with Pfizer (PFE). 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For March 13, 2023
Via Benzinga
Illumina, Seagen And Other Big Stocks Moving Higher On Monday
U.S. stocks traded slightly lower, with the Nasdaq Composite dropping around 0.2% on Monday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Pfizer Officially Nabs Seagen For $43 Billion; Provention Soars On Sanofi Deal
Pfizer expects Seagen to add at least $10 billion to its topline in 2030. 
Via Investor's Business Daily
Seagen's $43B Deal To Double Pfizer's Early-Stage Oncology Pipeline, Seagen Says Is Right Step
Via Benzinga
Pfizer Is Sending Seagen Stock Soaring Monday: What's Going On?
Seagen Inc (NASDAQ: SGEN) shares are trading higher Monday after Pfizer Inc (NYSE: PFE) announced plans to acquire the global biotech company. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We're starting off the week with a breakdown of the biggest pre-market stock movers traders need to know about for Monday! 
Via InvestorPlace
Pfizer Is Targeting an Acquisition That Could Be a Game Changer for Its Business
The company is rumored to be interested in buying Seagen. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.